Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
GLP-1 Receptor Agonists and the Risk of Thyroid CancerDiabetes care, 2023-02, Vol.46 (2), p.384-390 [Peer Reviewed Journal]2023 by the American Diabetes Association. ;Copyright American Diabetes Association Feb 2023 ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0149-5992 ;EISSN: 1935-5548 ;DOI: 10.2337/dc22-1148 ;PMID: 36356111Full text available |
|
2 |
Material Type: Article
|
Sodium-glucose cotransporter protein-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trialsBMJ (Online), 2021-01, Vol.372, p.m4573 [Peer Reviewed Journal]Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2021 Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. BMJ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2021 BMJ ;ISSN: 1756-1833 ;ISSN: 0959-8138 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.m4573 ;PMID: 33441402Full text available |
|
3 |
Material Type: Article
|
Euglycemic Diabetic Ketoacidosis: A Potential Complication of Treatment With Sodium-Glucose Cotransporter 2 InhibitionDiabetes care, 2015-09, Vol.38 (9), p.1687-1693 [Peer Reviewed Journal]2015 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. ;Copyright American Diabetes Association Sep 2015 ;2015 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. 2015 ;ISSN: 0149-5992 ;EISSN: 1935-5548 ;DOI: 10.2337/dc15-0843 ;PMID: 26078479 ;CODEN: DICAD2Full text available |
|
4 |
Material Type: Article
|
Shared Risk Factors in Cardiovascular Disease and CancerCirculation (New York, N.Y.), 2016-03, Vol.133 (11), p.1104-1114 [Peer Reviewed Journal]2016 by the American College of Cardiology Foundation and the American Heart Association, Inc. ;2016 American Heart Association, Inc. ;ISSN: 0009-7322 ;EISSN: 1524-4539 ;DOI: 10.1161/CIRCULATIONAHA.115.020406 ;PMID: 26976915Full text available |
|
5 |
Material Type: Article
|
Efficacy and Safety of Once-Weekly Semaglutide Versus Exenatide ER in Subjects With Type 2 Diabetes (SUSTAIN 3): A 56-Week, Open-Label, Randomized Clinical TrialDiabetes care, 2018-02, Vol.41 (2), p.258-266 [Peer Reviewed Journal]2017 by the American Diabetes Association. ;Copyright American Diabetes Association Feb 1, 2018 ;ISSN: 0149-5992 ;EISSN: 1935-5548 ;DOI: 10.2337/dc17-0417 ;PMID: 29246950Full text available |
|
6 |
Material Type: Article
|
Microbiota and diabetes: an evolving relationshipGut, 2014-09, Vol.63 (9), p.1513-1521 [Peer Reviewed Journal]Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions. ;Copyright: 2014 Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions ;ISSN: 0017-5749 ;EISSN: 1468-3288 ;DOI: 10.1136/gutjnl-2014-306928 ;PMID: 24833634 ;CODEN: GUTTAKFull text available |
|
7 |
Material Type: Article
|
Sodium glucose cotransporter 2 inhibitors and risk of serious adverse events: nationwide register based cohort studyBMJ (Online), 2018-11, Vol.363, p.k4365 [Peer Reviewed Journal]Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions. ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions 2018 BMJ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to 2018 BMJ ;ISSN: 0959-8138 ;ISSN: 1756-1833 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.k4365 ;PMID: 30429124Full text available |
|
8 |
Material Type: Article
|
A Randomized, Open-Label Comparison of Once-Weekly Insulin Icodec Titration Strategies Versus Once-Daily Insulin Glargine U100Diabetes care, 2021-07, Vol.44 (7), p.1595-1603 [Peer Reviewed Journal]2021 by the American Diabetes Association. ;Copyright American Diabetes Association Jul 1, 2021 ;2021 by the American Diabetes Association 2021 ;ISSN: 0149-5992 ;EISSN: 1935-5548 ;DOI: 10.2337/dc20-2878 ;PMID: 33875484Full text available |
|
9 |
Material Type: Article
|
Drug-induced mitochondrial dysfunction and cardiotoxicityAmerican journal of physiology. Heart and circulatory physiology, 2015-11, Vol.309 (9), p.H1453-H1467 [Peer Reviewed Journal]Copyright © 2015 the American Physiological Society. ;Copyright © 2015 the American Physiological Society 2015 American Physiological Society ;ISSN: 0363-6135 ;EISSN: 1522-1539 ;DOI: 10.1152/ajpheart.00554.2015 ;PMID: 26386112 ;CODEN: AJPPDIFull text available |
|
10 |
Material Type: Article
|
Dasiglucagon-A Next-Generation Glucagon Analog for Rapid and Effective Treatment of Severe Hypoglycemia: Results of Phase 3 Randomized Double-Blind Clinical TrialDiabetes care, 2021-06, Vol.44 (6), p.1361 [Peer Reviewed Journal]2021 by the American Diabetes Association. ;EISSN: 1935-5548 ;DOI: 10.2337/dc20-2995 ;PMID: 35239971Full text available |
|
11 |
Material Type: Article
|
Empagliflozin reduces blood pressure in patients with type 2 diabetes and hypertensionDiabetes care, 2015-03, Vol.38 (3), p.420-428 [Peer Reviewed Journal]2015 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. ;Copyright American Diabetes Association Mar 2015 ;ISSN: 0149-5992 ;EISSN: 1935-5548 ;DOI: 10.2337/dc14-1096 ;PMID: 25271206 ;CODEN: DICAD2Full text available |
|
12 |
Material Type: Article
|
Dipeptidyl peptidase-4 inhibitors and risk of heart failure in type 2 diabetes: systematic review and meta-analysis of randomised and observational studiesBMJ (Online), 2016-02, Vol.352, p.i610-i610 [Peer Reviewed Journal]Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions. ;Copyright BMJ Publishing Group LTD Feb 17, 2016 ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to 2016 BMJ ;ISSN: 1756-1833 ;ISSN: 0959-8138 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.i610 ;PMID: 26888822Full text available |
|
13 |
Material Type: Article
|
Diabetic Ketoacidosis and Related Events in the Canagliflozin Type 2 Diabetes Clinical ProgramDiabetes care, 2015-09, Vol.38 (9), p.1680-1686 [Peer Reviewed Journal]2015 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. ;Copyright American Diabetes Association Sep 2015 ;2015 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. 2015 ;ISSN: 0149-5992 ;EISSN: 1935-5548 ;DOI: 10.2337/dc15-1251 ;PMID: 26203064 ;CODEN: DICAD2Full text available |
|
14 |
Material Type: Article
|
Association of Organic Cation Transporter 1 With Intolerance to Metformin in Type 2 Diabetes: A GoDARTS StudyDiabetes (New York, N.Y.), 2015-05, Vol.64 (5), p.1786-1793 [Peer Reviewed Journal]2015 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. ;Copyright American Diabetes Association May 2015 ;ISSN: 0012-1797 ;EISSN: 1939-327X ;DOI: 10.2337/db14-1388 ;PMID: 25510240 ;CODEN: DIAEAZFull text available |
|
15 |
Material Type: Article
|
Insulin resistance as a physiological defense against metabolic stress: implications for the management of subsets of type 2 diabetesDiabetes (New York, N.Y.), 2015-03, Vol.64 (3), p.673-686 [Peer Reviewed Journal]2015 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. ;Copyright American Diabetes Association Mar 2015 ;2015 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. 2015 ;ISSN: 0012-1797 ;EISSN: 1939-327X ;DOI: 10.2337/db14-0694 ;PMID: 25713189 ;CODEN: DIAEAZFull text available |
|
16 |
Material Type: Article
|
Activation and Inhibition of Sodium-Hydrogen Exchanger Is a Mechanism That Links the Pathophysiology and Treatment of Diabetes Mellitus With That of Heart FailureCirculation (New York, N.Y.), 2017-10, Vol.136 (16), p.1548-1559 [Peer Reviewed Journal]2017 by the American College of Cardiology Foundation and the American Heart Association, Inc. ;2017 American Heart Association, Inc. ;ISSN: 0009-7322 ;EISSN: 1524-4539 ;DOI: 10.1161/CIRCULATIONAHA.117.030418 ;PMID: 29038209Full text available |
|
17 |
Material Type: Article
|
Cardiovascular Effects of New Oral Glucose-Lowering Agents: DPP-4 and SGLT-2 InhibitorsCirculation research, 2018-05, Vol.122 (10), p.1439-1459 [Peer Reviewed Journal]2018 American Heart Association, Inc. ;2018 The Authors. ;2018 The Authors. 2018 ;ISSN: 0009-7330 ;ISSN: 1524-4571 ;EISSN: 1524-4571 ;DOI: 10.1161/CIRCRESAHA.117.311588 ;PMID: 29748368Full text available |
|
18 |
Material Type: Article
|
A randomized controlled trial of metformin on left ventricular hypertrophy in patients with coronary artery disease without diabetes: the MET-REMODEL trialEuropean heart journal, 2019-11, Vol.40 (41), p.3409-3417 [Peer Reviewed Journal]The Author(s) 2019. Published by Oxford University Press on behalf of the European Society of Cardiology. 2019 ;The Author(s) 2019. Published by Oxford University Press on behalf of the European Society of Cardiology. ;ISSN: 0195-668X ;EISSN: 1522-9645 ;DOI: 10.1093/eurheartj/ehz203 ;PMID: 30993313Full text available |
|
19 |
Material Type: Article
|
Efpeglenatide and Clinical Outcomes With and Without Concomitant Sodium-Glucose Cotransporter-2 Inhibition Use in Type 2 Diabetes: Exploratory Analysis of the AMPLITUDE-O TrialCirculation (New York, N.Y.), 2022-02, Vol.145 (8), p.565-574 [Peer Reviewed Journal]ISSN: 0009-7322 ;EISSN: 1524-4539 ;DOI: 10.1161/CIRCULATIONAHA.121.057934 ;PMID: 34775781Full text available |
|
20 |
Material Type: Article
|
Shift to Fatty Substrate Utilization in Response to Sodium-Glucose Cotransporter 2 Inhibition in Subjects Without Diabetes and Patients With Type 2 DiabetesDiabetes (New York, N.Y.), 2016-05, Vol.65 (5), p.1190-1195 [Peer Reviewed Journal]2016 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. ;Copyright American Diabetes Association May 2016 ;ISSN: 0012-1797 ;EISSN: 1939-327X ;DOI: 10.2337/db15-1356 ;PMID: 26861783 ;CODEN: DIAEAZFull text available |